
Contract manufacturing · India
Allrite Group runs five manufacturing units in Baddi, India. Our oral solid dose plant, Unit-II, was built in 2023 for regulated markets and has completed its EU GMP inspection by the Malta Medicines Authority, with no critical findings. We make tablets, hard capsules and pellets for licence holders who need capacity, flexible batch sizes and complete documentation.
8.1 bn
Tablets a year
960 m
Hard capsules a year
216 t
Pellets a year
28–3,200 kg
Capsule batch sizes
The company
Allrite Group began in 2010 as Allkind Healthcare with a single oral liquid unit. It now operates five facilities and four dedicated formulation & development sections, manufacturing pharmaceutical, cosmetic and herbal products for some of India's largest healthcare names.
Our site is located in Baddi, Himachal Pradesh — India's principal pharmaceutical cluster — approximately 50 km from Chandigarh airport, giving reliable access to raw material supply chains and export logistics.
Capabilities
Tablets, film & sugar coated tablets and hard gelatin capsules across two dedicated blocks, with in-line weight and hardness monitoring.
1.2bn tablets / 200m capsules monthly
Syrups, suspensions and drops produced on a validated purified water system with automated filling and sealing lines.
15m units monthly
Creams, ointments and gels manufactured across eight segregated areas with vacuum homogenising and tube filling.
Eight dedicated suites
Dermatological lotions, serums and cosmetic formulations produced to GMP and GLP standards for retail-ready brands.
Full private label service
Single-dose sachets for powders, granules and effervescent formats with automated four-side sealing.
7.5m sachets monthly
Medicated, cosmetic and herbal soap manufacturing including milling, plodding, stamping and carton packing.
18m bars monthly
Quality & compliance
Unit-II, our oral solid dose plant, was inspected by the Malta Medicines Authority, an EU competent authority, with no critical findings.

UK & EU partners
Importing into Great Britain, Northern Ireland or the EU places clear obligations on the brand owner and the importer. We structure our supply so that your side of that chain is straightforward.
Medicines for the UK and EU are made at Unit-II, our EU-inspected oral solid dose plant. We manufacture to your specification and supply finished, fully documented product to your licensed (MIA) importer or distributor in the UK or EU. Artwork, leaflet and pack formats are produced to UK and EU requirements.
For cosmetics we supply the technical data required for a UK and EU Product Information File — formulation breakdown, safety data, CPSR inputs, stability and PAO evidence, and INCI-ready labelling.
Blister, bottle, tube, sachet and carton formats with tamper-evident sealing, batch and expiry coding, and 2D barcode capability for FMD-style pack requirements.
Export documentation, temperature-controlled handling and consolidated sea or air freight from our Baddi site, 50 km from Chandigarh airport, to UK and EU ports.
Medicinal products placed on the UK or EU market require an appropriately licensed importer and QP certification within the territory. We manufacture and document to support that process; we do not act as your UK MIA holder or Responsible Person.
How we work
Share your brief, target specification and volumes. We confirm feasibility, format and indicative pricing within five working days.
Our four F&D sections develop or match the formulation and issue pilot samples with a draft specification.
Stability studies, analytical method validation and the full technical dossier are completed before commercial supply.
Scheduled production, QC release and export shipment against agreed lead times and forecast.
Contact
Send your product brief, target specification and indicative annual volumes. We respond to UK and EU enquiries within two working days.